Literature DB >> 20019833

The War on Cancer rages on.

Alnawaz Rehemtulla1.   

Abstract

In 1971, the "War on Cancer" was launched by the US government to cure cancer by the 200-year anniversary of the founding of the United States of America, 1976. This article briefly looks back at the progress that has been made in cancer research and compares progress made in other areas of human affliction. While progress has indeed been made, the battle continues to rage on.

Entities:  

Mesh:

Year:  2009        PMID: 20019833      PMCID: PMC2794506          DOI: 10.1593/neo.91866

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  409 in total

1.  Hsf1 is required for the nuclear translocation of p53 tumor suppressor.

Authors:  Qiang Li; Rebecca A Feldman; Vijayababu M Radhakrishnan; Steven Carey; Jesse D Martinez
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

2.  Decoy receptor 3 is a prognostic factor in renal cell cancer.

Authors:  Stephan Macher-Goeppinger; Sebastian Aulmann; Nina Wagener; Benjamin Funke; Katrin E Tagscherer; Axel Haferkamp; Markus Hohenfellner; Sunghee Kim; Frank Autschbach; Peter Schirmacher; Wilfried Roth
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

3.  Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

Authors:  Svetlana A Tsareva; Richard Moriggl; Florian M Corvinus; Bernd Wiederanders; Alexander Schütz; Boris Kovacic; Karlheinz Friedrich
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

4.  Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer.

Authors:  Dong Choon Park; Seung Geun Yeo; Mark R Wilson; Justin J Yerbury; Joseph Kwong; William R Welch; Yang Kyu Choi; Michael J Birrer; Samuel C Mok; Kwong-Kwok Wong
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

5.  HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.

Authors:  Ting Chen; Xu-Dong Tang; Yin Wan; Ling Chen; Song-Tao Yu; Zhen Xiong; Dian-Chun Fang; Guang-Ping Liang; Shi-Ming Yang
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

6.  Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells.

Authors:  Mark A Scheper; Mark E Shirtliff; Timothy F Meiller; Brian M Peters; Mary Ann Jabra-Rizk
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

7.  Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot study.

Authors:  Soha Salama El Sheikh; Hanna M Romanska; Paul Abel; Jan Domin; El-Nasir Lalani
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

8.  Host A(2B) adenosine receptors promote carcinoma growth.

Authors:  Sergey Ryzhov; Sergey V Novitskiy; Rinat Zaynagetdinov; Anna E Goldstein; David P Carbone; Italo Biaggioni; Mikhail M Dikov; Igor Feoktistov
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

9.  Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas.

Authors:  Lukasz-Filip Grochola; Thomas Greither; Helge W Taubert; Peter Möller; Uwe Knippschild; Andrej Udelnow; Doris Henne-Bruns; Peter Würl
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

10.  C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis.

Authors:  Christoph Wiesner; Sanaa M Nabha; Emanuel Burck Dos Santos; Hamilto Yamamoto; Hong Meng; Sebastian W Melchior; Fernando Bittinger; Joachim W Thüroff; Robert L Vessella; Michael L Cher; R Daniel Bonfil
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

View more
  3 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

Review 3.  Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers.

Authors:  Joe Abdo; David L Cornell; Sumeet K Mittal; Devendra K Agrawal
Journal:  Front Oncol       Date:  2018-03-28       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.